GH Research Plc GHRS
NASDAQ · United States · Health Technology
$22.87-0.61 (-2.60%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.23 | -0.30 | +24.3% | $0 | — | +3.9%$29.13→$30.27 |
| Q1 2026 | 2026-05-14 | -0.31 | -0.27 | -14.8% | — | — | -2.2%$21.88→$21.39 |
| Q4 2025 | 2026-03-05 | -0.22 | -0.27 | +18.5% | — | — | -0.4%$15.99→$15.93 |
| Q3 2025 | 2025-11-06 | -0.23 | -0.23 | 0.0% | — | — | -0.7%$13.59→$13.50 |
| Q2 2024 | 2024-09-03 | -0.20 | -0.22 | +9.1% | — | — | — |
| Q1 2024 | 2024-05-03 | -0.15 | -0.22 | +31.8% | — | — | — |
| Q4 2023 | 2024-02-29 | -0.21 | -0.20 | -5.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.